-
Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder
Lokkerbol, J., Wijnen, B., Ruhe, H. G., Spijker, J., Morad, A., Schoevers, R., de Boer, M. K., Cuijpers, P. & Smit, F., 2021, In: Expert review of pharmacoeconomics & outcomes research. 21, 5, p. 1031-1042 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis
Wijnen, B. F. M., Thielen, F. W., Konings, S., Feenstra, T., van der Gaag, M., Veling, W., de Haan, L., Ising, H., Hiligsmann, M., Evers, S. M. A. A., Smit, F. & Lokkerbol, J., 3 May 2020, In: Expert review of pharmacoeconomics & outcomes research. 20, 3, p. 269-279 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Begemann, M. J. H., Thompson, I. A., Veling, W., Gangadin, S. S., Geraets, C. N. W., van 't Hag, E., Müller-Kuperus, S. J., Oomen, P. P., Voppel, A. E., van der Gaag, M., Kikkert, M. J., van Os, J., Smit, H. F. E., Knegtering, R. H., Wiersma, S., Stouten, L. H., Gijsman, H. J., Wunderink, L., Staring, A. B. P. & Veerman, S. R. T. & 17 others, , 7 Feb 2020, In: Trials. 21, 1, 147.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
